REGN-EB3

E106452 UNEXPLORED

REGN-EB3 is a monoclonal antibody cocktail developed by Regeneron to treat Ebola virus disease, shown to significantly reduce mortality in clinical trials.

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

2018–2020 Kivu Ebola epidemic in the Democratic Republic of the Congo → treatmentUsed → REGN-EB3 ⓘ